Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Sarcoma 2 Triple Negative Breast Neoplasms 1 Rectal Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Bone Neoplasms 1

Interventions

Dexamethasone 45 Bortezomib 21 Lenalidomide 19 Cyclophosphamide 19 daratumumab 16 Calcium Dobesilate 13 Thalidomide 12 Melphalan 11 carfilzomib 9 Prednisone 7 pomalidomide 6 Peripheral Blood Stem Cell Transplantation 6 Doxorubicin 6 Filgrastim 5 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4 Vincristine 4 isatuximab 3 Interferon-alpha 3 Etoposide 3 selinexor 2 sargramostim 2 ixazomib 2 elotuzumab 2 cobimetinib 2 Steroids 2 Radiotherapy 2 Microarray Analysis 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Multiple Myeloma × olaparib × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡